Exploring how pharmaceutical teams can reduce packaging impact while maintaining patient safety, usability, and regulatory compliance through evidence-led, system-level decisions.
This article challenges why reduced-risk products have failed to gain mass adoption, reframes the problem through smoker psychology, and proposes a strategic roadmap to accelerate meaningful tobacco harm reduction.
This article examines why precision delivery has become the defining factor in cell and gene therapy success, explores how accuracy in location, distribution and dose can be engineered and demonstrated, and shows how a minimum viable product approach to delivery device development can help translate CGTs into safe, scalable clinical outcomes.
Delivering therapeutics into the brain remains one of the greatest challenges in tackling neurodegenerative disease. Modern drug modalities demand delivery systems engineered with precision, safety, and modality-specific requirements in mind.
Two-component injectables promise more stable, effective treatments but create new hurdles in reconstitution and delivery. From lyophilised powders to dual-chamber systems, this article explores how device innovation is making complex therapies simpler, safer, and more accessible beyond the clinic.
This article explores why heated tobacco remains niche despite major investment, showing how products prioritise compliance over experience and miss the simplicity and ritual smokers want. True progress will require rethinking design, physics, and industry-wide collaboration.
This article explores why most smokers haven’t embraced reduced-risk products, revealing how current vape and heated tobacco tech fails to deliver the ritual, satisfaction, and simplicity smokers still seek.
Our work with Credence MedSystems won a 2025 Red Dot Design Concept Award – but more importantly, it could change the lives of countless people who need to self-administer two drugs in one injection at home. Read more on the three insightsbehind project success.
This article explores why most smokers haven’t embraced reduced-risk products, revealing how current vape and heated tobacco tech fails to deliver the ritual, satisfaction, and simplicity smokers still seek.
This article, featuring insights from James Blakemore and Leigh Shelford, explores how ESCMID 2025 marked a shift from technology-led innovation to outcome-led diagnostics. Covering key themes including AMR, syndromic testing, sequencing, and AI, it highlights why usability, integration, and real-world impact are now critical to platform success.
This article, featuring insights from Tom Brittain, James Boonzaier and Jack Hornsby – the RAS leadership team at Cambridge Design Partnership – explores how a skunkworks approach, underpinned by capability, capacity and culture, enables surgical robotics companies to accelerate development, reduce risk, and bring new RAS technologies to market with speed and confidence.
This article, authored by Steve Augustyn, featuring insights from Krai Chatamra, VP of Clinical Development at Intrance Medical Systems, explores the necessity of advanced therapies that provide consistent symptom control to improve patient outcomes and enable a more independent lifestyle.